首页 飞利浦(usPHG)-基本信息

飞利浦(usPHG)-基本信息

日报更新时间:

周报更新时间:04-18 04:06

行情信息

今开价:60.0

最高价:60.72

成交量:663467.0

昨收价:59.9

最低价:59.97

最新价:60.53

行情图标
概要信息

中文名称:飞利浦


英文名称:Royal Philips NV


行业:消费品


简介:Koninklijke Philips N.V.于1891年在埃因霍温注册成立,是一家多元化的科技公司,主要生产照明、家庭电器、医疗系统


电话:31-20-5977232,31-20-5977222


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 持股信息
  • 领导人信息

荷兰皇家飞利浦电子公司(荷兰语:Koninklijke Philips Electronics N.V.,英语:Royal Dutch Philips Electronics Ltd.),简称飞利浦(Philips),是荷兰的跨国电子公司,总部设在阿姆斯特丹。由赫拉德·飞利浦(Gerard Philips)和父亲弗雷德里克·飞利浦(Frederik Philips)于1891年在荷兰埃因霍温创建,在全球60多个国家有10万多名雇员,是世界上最大的电子公司之一。飞利浦有三个主要部门:飞利浦消费电子产品(原飞利浦消费电子、飞利浦家电及个人护理),飞利浦医疗保健(原飞利浦医疗系统)和飞利浦照明,截至2012年飞利浦是世界上最大的照明产品制造商(飞利浦的LED灯是家喻户晓了吧?)。 飞利浦消费电子产品:提供母婴护理产品、口腔护理和疼痛管理产品、男性护肤和美容产品、厨房用具,咖啡,衣物护理,地板护理,和空气净化产品。 飞利浦医疗保健:提供诊断成像解决方案,包括:计算机断层扫描、磁共振成像、先进的分子成像和X射线诊断、综合临床解决方案、图像引导治疗方案、介入影像与治疗设备;还提供病人床边患者临床信息监控解决方案、病人的分析和监控、临床决策支持系统、食疗保健产品、呼吸监测装置、患者监护和食疗保健消耗品、客户服务;还提供先进的医疗保健IT、临床和影像信息进行放射学和心脏病、医学影像存档与通讯系统、集成电子病历系统、临床支持、远程主动监控服务。 飞利浦照明:参与开发、制造各种照明产品和服务,包括光源和电子产品,如LED、生态卤钨灯、荧光灯、放电和白炽灯光源,以及电子和电磁齿轮应用,模块和驱动程序;功能性的,装饰性,生活方式和场景设定灯具;并控制和城市美化,道路,体育照明,办公照明,商店/酒店照明和工业照明灯具。飞利浦Koninklijke Philips(PHG)历史沿革: 1891年,赫拉德·飞利浦(Gerard Philips)和父亲弗雷德里克·飞利浦(Frederik Philips)在埃因霍温创建了飞利浦公司; 1895年,飞利浦经历了接近破产的困难之后,赫拉德的弟弟安东·飞利浦(Anton Philips)加入公司,给公司带来了商业活力,公司开始快速增长; 1907年,飞利浦金属丝电灯泡有限公司(N.V. Philips’ Metaalgloeilampfabriek)于埃因霍温成立; 1912年,成立飞利浦电灯泡有限公司(N.V. Philips' Gloeilampenfabrieken); 20世纪20年代,公司开始生产其他产品,如真空管; 1927年3月11日,飞利浦成立短波电台PCJJ(后来PCJ)并在1929年成立姐妹台PHI; 1939年,推出Philishave电动剃须刀(使用Norelco品牌名称在美国销售); 1940年5月9日,飞利浦管理层得知德国将于第二天入侵荷兰,安东·飞利浦和他的女婿以及其他飞利浦家庭成员(安东的儿子弗里茨·飞利浦是唯一留在荷兰的飞利浦家庭成员,他通过说服纳粹相信382犹太人在生产过程中的必不可少,成功让这些犹太人保住了性命,1996年,他因拯救数以百计犹太人的行动被以色列犹太大屠杀纪念馆评为国际义人),携带大量公司资本逃到美国,在整个战争期间在美国管理经营他们的“北美飞利浦公司”,同时,公司注册地转移到荷属安的列斯以保持其荷兰身份; 1946年,国有化两个短波电台,更名为荷兰国际广播电台,荷兰国际服务; 1949年,公司搬回到荷兰,总部设在埃因霍温,开始销售电视机; 1950年,飞利浦唱片成立; 1963年,飞利浦公司推出卡式录音带,获得巨大成功; 1972年,飞利浦在英国推出世界上第一个家用录像机,N1500; 1999年,飞利浦与乐金电子合资成立LG.Philips(2006年宣告破产); 2006年1月20日,Philips Electronics NV宣布以7.5亿美金收购Lifeline Systems Inc; 2006年,飞利浦出售半导体业务,收购的财团把飞利浦半导体业务更名为恩智浦半导体; 2007年3月,飞利浦与台湾建兴电子合资成立飞利浦建兴数位科技股份有限公司(Philips & Lite-On Digital Solutions Corporation); 2013年1月27日,飞利浦将旗下的音频、视频、多媒体及配件业务以1.5亿欧元出售予日本电子厂商船井电机(Funai); 2014年4月28日,Philips同意以1.35亿美金出售旗下Woox Innovations子公司给Gibson Brands; 2015年2月,Philips收购Volcano Corporation以加强在非侵入性手术和成像领域的领导地位; 2015年4月2日,以中资为主的金沙江GO Scale Capital (金沙江创业投资与橡树投资伙伴联合组成的基金) 牵头,亚太资源开发投资有限公司和南昌工业控股集团有限公司等中资、外资财团联合组成的并购基金,,与荷兰皇家飞利浦公司签署协议,以33亿美元收购从飞利浦分拆出来的Lumileds 80.1%股权以及“飞利浦”商标20年使用权。飞利浦保留Lumileds 19.9%的股权; 近些年来,飞利浦收购的公司包括:Amperex Electronic、Magnavox、Signetics、Mullard、VLSI Technology、Agilent Healthcare Solutions Group、Marconi Medical Systems、ATL Ultrasound、ADAC Laboratories、Sectra Mamea AB、Westinghouse Electric部分资产、Philco的消费者电子产品业务和Sylvania Electric Products(收购后,飞利浦放弃了Sylvania商标,目前被Havells Sylvania持有); 2016年5月31日,飞利浦灯饰制造(深圳)有限公司提前解散,停止运营。

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Hartford Funds Management Company, LLC 496464 0.05% -5432 -1.08% 2019-07-31
Wells Fargo & Co 1144022 0.13% 31160 2.80% 2019-03-31
BlackRock Advisors LLC 1158513 0.13% -179467 -13.41% 2019-07-31
TCW Asset Management Co 1172385 0.13% -111621 -8.69% 2019-03-31
TCW Group Inc 1172385 0.13% -111621 -8.69% 2019-03-31
Arrowstreet Capital Limited Partnership 2782253 0.31% -953381 -25.52% 2019-03-31
Wellington Management Company LLP 3298310 0.36% 1183917 55.99% 2019-03-31
Bank of America Corporation 4197961 0.46% 552525 15.16% 2019-03-31
BlackRock Inc 6945570 0.76% 936983 15.59% 2019-03-31
Hotchkis & Wiley Capital Management LLC 1099117 0.12% -55313 -4.79% 2019-03-31
TPG Group Holdings (SBS) Advisors Inc 1073437 0.12% -127217 -10.60% 2019-03-31
Morgan Stanley - Brokerage Accounts 983861 0.11% 52406 5.63% 2019-03-31
Hardman Johnston Global Advisors LLC 634266 0.07% 18877 3.07% 2019-03-31
Parametric Portfolio Associates LLC 669877 0.07% 12670 1.93% 2019-03-31
Dimensional Fund Advisors LP 825025 0.09% 20737 2.58% 2019-07-31
Dimensional Fund Advisors, Inc. 895714 0.10% -6639 -0.74% 2019-03-31
Northern Trust Corp 907833 0.10% 12240 1.37% 2019-03-31
Northern Trust Investments N A 907833 0.10% 12240 1.37% 2019-03-31
Morgan Stanley Smith Barney LLC 908952 0.10% -12661 -1.37% 2019-03-31
AXA Equitable Funds Management Group, LLC 923075 0.10% -- -- 2019-07-31
JANE STREET GROUP, LLC 594417 0.07% 316900 114.19% 2018-12-31
Ameriprise Financial Inc 1405982 0.15% -123594 -8.08% 2018-12-31
Ameriprise Financial Services Inc 1305714 0.14% -118952 -8.35% 2018-12-31
Samlyn Capital, LLC 1228668 0.13% 78178 6.80% 2018-12-31
Criterion Capital Management,LLC 808066 0.09% -1032599 -56.10% 2018-09-30
Steadfast Capital Management LLC 1067116 0.12% 5605 0.53% 2018-09-30
Vanguard 998311 0.11% -2573503 -72.05% 2018-11-30
Fidelity Management & Research Company 1011421 0.11% 950008 1546.92% 2018-11-30
Merrill Lynch & Co Inc 1051074 0.11% -142439 -11.93% 2018-06-30
Columbia Management Company 1063174 0.11% 162104 17.99% 2018-06-30
TPG Capital LP 1155119 0.12% -- -- 2018-09-30
Managed Account Advisors LLC 2532316 0.27% 353622 16.23% 2018-06-30
M.D. Sass, LLC 900065 0.10% -183740 -16.95% 2018-06-30
Wells Fargo Advisors, LLC 897594 0.10% 25277 2.90% 2018-06-30
SKBA Capital Management LLC 564980 0.06% -11090 -1.93% 2018-06-30
Johnston Asset Management 641578 0.07% -16808 -2.55% 2018-06-30
TCW Investment Management Co 553215 0.06% -30300 -5.19% 2018-07-31
NWQ Investment Management Co LLC 2147721 0.23% -179372 -7.71% 2017-12-31
Citadel Advisors Llc 2374435 0.26% 1217071 105.16% 2017-12-31
Morgan Stanley & Co Inc 816891 0.09% 646949 380.69% 2017-12-31
Becker Capital 755089 0.08% -101000 -11.80% 2017-12-31
Renaissance Technologies Corp 1085178 0.12% 802100 283.35% 2017-12-31
Senator Investment Group LP 2855000 0.31% 675000 30.96% 2017-12-31
Fidelity Management and Research Company 1254721 0.13% 1080687 620.96% 2017-09-30
Robeco Investment Management, Inc. 8051633 0.86% -3465377 -30.09% 2017-09-30
Federated Global Inv Mgmt Corp 677697 0.07% -2 -- 2017-09-30
Two Sigma Investments LLC 1029927 0.11% 213240 26.11% 2017-06-30
Chartwell Investment Partners, LLC 773065 0.08% -8695 -1.11% 2016-09-30
Deutsche Bank AG 878332 0.10% 187661 27.17% 2016-09-30
Thornburg Investment Management Inc 887318 0.10% -67589 -7.08% 2016-09-30
Levin Capital Strategies, L.P. 955984 0.10% 240000 33.52% 2016-09-30
Cambiar Investors LLC 4167951 0.45% 4487 0.11% 2016-09-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Barrett Opportunity Fund 115710 0.01% -- -- 2019-06-30
BGF US Basic Value Fund 296149 0.03% 2300 0.78% 2019-04-30
Vanguard Capital Value Fund 298363 0.03% -4234 -1.40% 2019-03-31
Desjardins American Equity Value Fund 337930 0.04% -- -- 2019-07-31
JNL/WMC Value Fund 390910 0.04% -13260 -3.28% 2019-03-31
Hartford Capital Appreciation HLS Fund 434278 0.05% -- -- 2019-06-30
DFA International Core Equity Portfolio 490731 0.05% 11513 2.40% 2019-06-30
EQ/BlackRock Basic Value Equity 723917 0.08% -- -- 2019-05-31
BlackRock Basic Value Fund 995338 0.11% -- -- 2019-06-30
SKBA Capital Value Plus-UBS 271300 0.03% -- -- 2019-06-30
Nationwide NVIT Multi-Mnger L/C Val Fund 246162 0.03% -- -- 2019-06-30
EQ/Large Cap Value Managed Volatil Port 199158 0.02% -- -- 2019-05-31
DFA Large Cap International Portfolio 118908 0.01% 6304 5.60% 2019-06-30
BlackRock Large Cap Value (SMA) - UBS 122672 0.01% 15821 14.81% 2019-06-30
Dynamic Global Equity Income 132800 0.01% 132800 -- 2019-04-30
New Alternatives Fund 150000 0.02% -- -- 2019-06-30
BlackRock Basic Value V.I. Fund 163175 0.02% -28370 -14.81% 2019-06-30
AST Hotchkis & Wiley Large-Cap Val Port 173038 0.02% -29146 -14.42% 2019-06-30
TCW Relative Value Dividend Fund 181367 0.02% -12100 -6.25% 2019-06-30
First Investors Growth and Income Fund 185500 0.02% -43000 -18.82% 2019-06-30
Destinations Large Cap Equity Fund 303124 0.03% -- -- 2019-05-31
BlackRock Mid Cap Dividend Fund 149600 0.02% -21500 -12.57% 2019-05-31
Arrowstreet Intl Eq EAFE CIT 146704 0.02% 51500 54.09% 2018-09-30
Arrowstreet Intl Eq EAFE Alpha Ext CIT 146704 0.02% 146704 -- 2018-09-30
Pru Ret Large Cap Val/Wellington SP 117418 0.01% 117418 -- 2019-03-31
ABN AMRO TCW US Equities 128745 0.01% -1405 -1.08% 2019-03-31
AXA Large Cap Value Managed Volatil Port 196848 0.02% 16450 9.12% 2019-02-28
MassMutual Select Fundamental Value Fund 219590 0.02% 8980 4.26% 2018-12-31
Dynamic Vario Protect 154222 0.02% 154222 -- 2018-05-31
VT III Vantagepoint Equity Income Fd 149993 0.02% 15220 11.29% 2018-11-30
Vanguard Windsor 998311 0.11% -2573503 -72.05% 2018-06-30
American Beacon Large Cap Value Fund 198327 0.02% -8900 -4.29% 2018-07-31
Federated Clover Value 677400 0.07% -- -- 2017-09-30
Boston Partners Large Cap Value Equity 707281 0.08% -284310 -28.67% 2017-09-30
Fidelity 772900 0.08% 772900 -- 2017-09-30
PGIM Jennison Equity Income Fund 203807 0.02% -- -- 2018-09-30
Barrett Opportunity 115710 0.01% -- -- 2018-06-30
DFA Large Cap International I 103823 0.01% -- -- 2018-07-31
AST Large-Cap Value 348084 0.04% -- -- 2018-07-31
BlackRock Basic Value V.I. 2 137051 0.01% 2700 2.01% 2018-07-31
AXA Large Cap Value Managed Volatil IA 142174 0.02% 1463 1.04% 2018-07-31
BlackRock Basic Value Instl 754730 0.08% -- -- 2018-07-31
Federated Clover Value A 677400 0.07% -- -- 2017-09-30
DFA International Core Equity I 545396 0.06% -- -- 2018-07-31
EQ/BlackRock Basic Value Equity IA 510136 0.05% 15739 3.18% 2018-07-31
JNL/WMC Value B 395070 0.04% -8850 -2.19% 2018-06-30
TCW Relative Value Dividend Apprec N 359467 0.04% -23200 -6.06% 2018-07-31
Hartford Capital Appreciation HLS IA 314478 0.03% -- -- 2018-07-31
Prudential Jennison Equity Income C 297754 0.03% -- -- 2018-07-31
New Alternatives A 150000 0.02% -- -- 2018-06-30
NVIT Multi-Manager Large Cap Value Y 180155 0.02% -1300 -0.72% 2018-07-31
American Beacon Lg Cap Value Inst 198327 0.02% -8900 -4.29% 2018-07-31
Vanguard Capital Value Inv 214600 0.02% -21400 -9.07% 2018-06-30
MassMutual Select Fundamental Value A 218700 0.02% -- -- 2018-06-30
First Investors Growth & Income A 250000 0.03% -- -- 2018-06-30
BlackRock U.S. Basic Value M 106420 0.01% 106420 -- 2017-09-30
Hotchkis & Wiley Large Cap Value I 190705 0.02% -15800 -7.65% 2018-04-30
AST Boston Partners Large-Cap Value 257001 0.03% 29473 12.95% 2017-03-31
Berwyn Income 125000 0.01% -392000 -75.82% 2017-10-31
Becker Value Equity Retail 104660 0.01% -38550 -26.92% 2017-10-31
JHancock Disciplined Value I 104857 0.01% -2121426 -95.29% 2017-11-30
DFA International Value I 111985 0.01% -11033 -8.97% 2017-11-30
Boston Partners Large Cap Value Equity Fund - Class G 707281 0.08% -284310 -28.67% 2017-09-30
PACE Large Co Value Equity P 157004 0.02% -5392 -3.32% 2017-07-31
Strategic Advisers 261292 0.03% 84812 48.06% 2016-12-31
Nuveen Pref Income Opps Fund 113800 0.01% -- -- 2016-12-31
Nuveen NWQ Flexible Income A 112400 0.01% 13000 13.08% 2016-12-31
Vanguard Windsor II Fund 1094921 0.10% -- -- 2015-09-30
Amundi Funds Equity US Relative Value 805948 0.10% 25558 3.30% 2015-06-30
Beutel Goodman Balanced Fund 646305 0.10% 22300 3.60% 2015-10-31
Vantagepoint Growth & Income Fund 343379 -- -- -- 2015-09-30
Beutel Goodman Global Equity Class 310517 -- -- -- 2015-10-31
Vantagepoint Aggressive Opp Fund 278462 -- -50600 -15.40% 2015-09-30
AST Large Cap Value 262260 -- -- -- 2015-09-30
NEI Ethical Global Dividend Fund 261352 -- -- -- 2015-09-30
Seasons Ser Tr Large Cap Value 142073 -- -- -- 2015-09-30
Hotchkis & Wiley Large Cap Value Fund 128563 -- -- -- 2015-09-30
Beutel Goodman International Equity Fund 127028 -- -- -- 2015-10-31
Vantagepoint Equity Income Fund 1185140 0.10% -- -- 2015-09-30

David E. I. Pyott David E. I. Pyott is a British businessperson who has been at the head of 7 different companies. Currently, he holds the position of Chairman of Bioniz Therapeutics, Inc., Chief Executive Officer & Director at Serica Technologies, Inc. and President of Vicept Therapeutics, Inc. He is also President at International Council of Ophthalmology Foundation and on the board of 13 other companies. He previously occupied the position of Head-Nutrition Division at Novartis AG and President & Chief Executive Officer of Sandoz Nutrition Corp. (a subsidiary of Novartis AG), Chairman at California Healthcare Institute and Chairman & Chief Executive Officer of Allergan, Inc. Dr. Pyott received a graduate degree from The University of Edinburgh and an MBA from London Business School.
Jackson Peter Tai Jackson Peter Tai is on the board of Eli Lilly & Co. and 9 other companies. Mr. Tai previously held the position of Vice Chairman & Chief Executive Officer for DBS Group Holdings Ltd. Vice Chairman & Chief Executive Officer of DBS Bank Ltd. and Chief Executive Officer of DBS Vickers Securities (USA), Inc. (both are subsidiaries of DBS Group Holdings Ltd.), Non-Executive Chairman, President & CEO at Brookstone, Inc., Managing Director-Investment Banking Division at J.P. Morgan & Co., Inc. (Old) and Member-Management Board at OSIM International Pte Ltd. Jackson Peter Tai received an undergraduate degree from Rensselaer Polytechnic Institute and an MBA from Harvard University.
Robert A. Cascella Robert A. Cascella is on the board of Celestica, Inc. and Chief Business Leader-Diagnosis & Treatment, EVP at Koninklijke Philips NV. Mr. Cascella previously occupied the position of Director at DySIS Medical Ltd., President, Chief Executive Officer & Director at Hologic, Inc., President, Chief Operating & Financial Officer at Fischer Imaging Corp., Managing Partner at CFG Capital LLC, Director-Accounting & Financial Planning at PerkinElmer, Inc. (United States), Chief Operating Officer & VP-Finance at NeoVision Corp. and Principal at American Cancer Society, Inc. He received an undergraduate degree from Fairfield University.
Christine A. Poon Christine A. Poon is Vice Chairman & Co-Secretary at Koninklijke Philips NV. She is also Executive-Management & Human Resources at Fisher College of Business and on the board of 7 other companies. She previously held the position of Director & Vice Chairman-Pharmaceuticals at Johnson & Johnson and President-International Medicines at Bristol-Myers Squibb Co. She received an undergraduate degree from Northwestern University, a graduate degree from St. Louis University and an MBA from Boston University.
Orit Gadiesh Ms. Orit Gadiesh is a Member-Supervisory Board at Koninklijke Philips NV, a Chairman at Bain & Co., Inc., a Director-Harvard Business School at Harvard University, a Director-Kellogg School at Northwestern University, a Director-Wharton School at University of Pennsylvania, a Member at Council on Foreign Relations, Inc., a Member at The International Business Council, a Principal at International Business Leaders Advisory Council and a Treasurer at The Massachusetts Business Roundtable. She is on the Board of Directors at Koninklijke Philips NV, Englishtown Ltd., Forum Mondial de L'Economie, Renova Management AG (Switzerland) and Renova Management AG. Ms. Gadiesh was previously employed as an Independent Non-Executive Director by WPP Plc, an Independent Non-Executive Director by WPP 2012 Ltd., a Trustee by Eisenhower Fellowships, Inc., and a Member by Greater Boston Chamber of Commerce. She also served on the board at Digitas, Inc., Federal Reserve Bank of Boston, The Peres Center for Peace, Think Tools AG and Vonage Holdings Corp. She received her MBA from Harvard Business School.
Jeroen van der Veer Jeroen van der Veer is a Netherlands; Dutch businessperson who has been at the helm of 13 different companies. He holds the position of Chairman-Supervisory Board of Royal Boskalis Westminster NV, Chairman-Supervisory Board for Platform B�0�1¨ta Techniek, Chairman-Supervisory Board at Nederlands Openluchtmuseum and Chairman-Supervisory Board at Koninklijke Philips NV. He is also Chairman-Supervisory Board at Delft University of Technology and Chairman for Stichting Het Concertgebouw Fonds and on the board of 7 other companies. He previously held the position of Chairman-Supervisory Board at NN Group NV, Chairman for European Round Table of Industrialists, Chairman-Supervisory Board for ING Groep NV and Chairman-Supervisory Board for ING Bank NV (a subsidiary of ING Groep NV) and Non-Executive Director at Royal Dutch Shell Plc Chief Executive Officer at Shell Chemicals LP and Chief Executive Officer at The Shell Transport & Trading Co. Ltd. (both are subsidiaries of Royal Dutch Shell Plc). He received an undergraduate degree from Delft University of Technology and a graduate degree from Erasmus University Rotterdam.
Jeroen Tas Founder of Mphasis Corp., Jeroen Tas is Chief Innovation & Strategy Officer, Executive VP at Koninklijke Philips NV. In the past he was Chief Information Officer at Koninklijke Philips NV CEO-Informatics Solutions & Services at Philips Healthcare and Head-International Marketing & Project Management at Philips Electronics Ltd. (both are subsidiaries of Koninklijke Philips NV), Senior Vice President for Citigroup, Inc. Member of Global Consumer Group and Principal at Transaction Technology, Inc. (both are subsidiaries of Citigroup, Inc.), Partner at Exigen Capital LP, Vice President & General Manager at EDS Co., Vice Chairman of Mphasis Ltd. and Head-International Marketing & Project Management at Digital Equipment Corp. Mr. Tas received an MBA and a graduate degree from the University of Amsterdam and a graduate degree and an MBA from Vrije Universiteit Amsterdam.
David E. I. Pyott Mr. Pieter Nota is Chief Marketing Officer & Executive Vice President at Royal Philips NV and Chief Executive Officer at Philips Consumer Lifestyle International BV. Mr. Nota was previously employed as Chief Marketing & Innovation Officer by Beiersdorf AG, Marketing Director & Member-Executive Board by Unilever Bestfoods Deutschland GmbH, Marketing Director & Member-Executive Board by Unilever Polska SA, Marketing Manager-Innovations Europe by Unilever Plc, and National Account Manager by Unilever NV. He also served on the board at GfK N�0�1�0�4rnberg eV.
Fran�0�1§ois Adrianus van Houten Fran�0�1§ois Adrianus van Houten is a Dutchman businessperson who has been at the helm of 7 different companies and currently occupies the position of Chief Executive Officer at Philips Lighting Electronics (Shanghai) Co. Ltd. and Chief Executive Officer of Royal Philips NV, Chief Executive Officer at Philips International BV (a subsidiary of Royal Philips NV). He is also on the board of Novartis AG, Vereniging Trustfonds Erasmus Universiteit Rotterdam, World Expo Rotterdam 2025 and Nl2025 and Member of European Round Table of Industrialists. In the past Fran�0�1§ois Adrianus van Houten occupied the position of Chief Executive Officer at NXP Semiconductors NV and President & Chief Executive Officer of Philips Semiconductors (a subsidiary of NXP Semiconductors NV), Chief Executive Officer at Airvision LLC, VP-International Sales & Operations at PKV Verm�0�1�0�9gensverwaltung AG and Chief Executive Officer at Philips Lighting Holding BV. He received a graduate degree from Erasmus University Rotterdam.
Ronald de Jong Ronald de Jong holds the position of Chairman of The Philips Foundation and Chief Human Resources Officer & Executive VP of Koninklijke Philips NV. He is also on the board of SNV Netherlands Development Organisation and Professor at the University of Tilburg. He previously occupied the position of Managing Director & SVP-Consumer Lifestyle at Philips GmbH. He received a graduate degree from Erasmus University Rotterdam.
Heino von Prondzynski Mr. Heino von Prondzynski is a Chairman at Quotient Ltd., a Chairman-Supervisory Board at Epigenomics AG and a Member-Supervisory Board at Koninklijke Philips NV. He is on the Board of Directors at The Binding Site Group Ltd., Koninklijke Philips NV and HTL-STREFA SA. Mr. von Prondzynski was previously employed as a Chairman by Nobel Biocare Holding AG, an Independent Director by Hospira, Inc., a Member-Supervisory Board by Epigenomics AG, an Independent Director-Supervisory Board by QIAGEN NV, a Chief Executive Officer-Diagnostics Division by F. Hoffmann-La Roche Ltd., a Chief Executive Officer by Roche Diagnostics Corp., a President-Vaccines Division by Chiron Corp., a General Manager by Bayer AG, a General Manager by Bayer SA (Brazil), and a Chief Executive Officer by Roche Diagnostic Systems, Inc. He also served on the board at BB Medtech AG, CaridianBCT, Inc., I-MED Radiology Network Ltd. and Tecan Group AG /Basel Government Employees/. He received his undergraduate degree from the University of M�0�1�0�4nster.
Mary Elizabeth Doherty Mary Elizabeth Doherty is on the board of Koninklijke Philips NV and 5 other companies. In the past Ms. Doherty was Group Director-International Finance at Tesco Plc, Chief Financial Officer & Director at Reckitt Benckiser Group Plc and Chief Financial Officer & Executive Director at Reckitt Benckiser Plc (a subsidiary of Reckitt Benckiser Group Plc), Chief Financial Officer & Executive Director at Brambles Ltd., Finance Director-Unilever Thai Holdings at Unilever Plc, Chief Financial Officer at Cognita Ltd. and Chief Financial Officer at Mint Hotel Ltd. Mary Elizabeth Doherty received an undergraduate degree from The University of Manchester.
A. Marc Harrison A. Marc Harrison is President, Chief Executive Officer & Trustee at Intermountain Health Care, Inc.
Neelam Dhawan Neelam Dhawan is on the board of Koninklijke Philips NV, ICICI Bank Ltd. and Yatra Online, Inc. In the past Ms. Dhawan was Managing Director at Microsoft Corp. (India) Pvt Ltd. and MD & VP-Global Sales & Alliance at Hewlett-Packard India Ltd. She received an MBA from Faculty of Management Studies.
Abhijit Bhattacharya Currently, Abhijit Bhattacharya is Co-President of OmniActive Health Technologies Ltd. and Chief Financial Officer & Executive Vice President of Koninklijke Philips NV. Mr. Bhattacharya is also on the board of Philips Lighting BV and Associate at The Institute of Cost & Works Accountants of India. In the past he held the position of Chief Operating Officer for ST-Ericsson SA, Director & Vice President at PPJ Healthcare Enterprises, Inc., Senior Vice President & Financial Controller at NXP Semiconductors NV, Chief Financial Officer of Philips India Ltd., CFO & Head-Investor Relations at Philips Healthcare, Vice President-Finance at ST-NXP Wireless and Financial Controller of Philips Semiconductors, Inc. Mr. Bhattacharya received a graduate degree from Sydenham College of Commerce & Economics.
Paulus Stoffels Paulus Stoffels founded Tibotec Virco NV. Dr. Stoffels is on the board of Koninklijke Philips NV, Crucell NV and Interuniversitair Micro-Electronica Centrum VZW and Chief Scientific Officer of Johnson & Johnson and Worldwide Chairman-Pharmaceuticals at Janssen Research & Development LLC. Dr. Stoffels previously occupied the position of Chief Executive Officer at Vircorp, Inc., President & Chief Executive Officer for Tibotec Virco NV and Global Head at Johnson & Johnson Pharmaceutical Research & Development LLC.
Pim Preesman Pim Preesman is Head-Investor Relations at Koninklijke Philips NV. He received an undergraduate degree from Maastricht University, an undergraduate degree from Erasmus University Rotterdam and an undergraduate degree from London School of Economics & Political Science.
Carla Kriwet Carla Kriwet is on the board of Carl Zeiss AG and Save the Children Deutschland and Member of Young Presidents' Organization, Inc. and Chief Business Leader & Executive Vice President at Koninklijke Philips NV. In the past she occupied the position of Member-Management Board at Dr�0�1¤gerwerk Verwaltungs AG, Director-Sales & Marketing at Dr�0�1¤gerwerk AG & Co. KGaA, Chief Executive Officer at Philips Deutschland GmbH, Principal at The Boston Consulting Group Ltd. and CEO-Homecare Division & Head-Healthcare Europe at Linde Gas Deutschland. She received an undergraduate degree from the University of St. Gallen and an undergraduate degree from Indian Institute of Technology New Delhi.
Sean Carney Sean Carney is Chief Design Officer at Philips Consumer Lifestyle International BV and Chief Design Officer at Koninklijke Philips NV. Mr. Carney received a graduate degree from Birmingham City University.
Ren�0�1�0�8 van Schooten Currently, Ren�0�1�0�8 van Schooten holds the position of Business Group Leader-Lamps at Signify NV. He is also CEO-Light Sources & Electronics at Philips Lighting Holding BV and Chief Financial Officer-Lighting Business at Koninklijke Philips NV. He received an undergraduate degree from Technische Universiteit Eindhoven.
Karen S�0�1�0�9rensen Karen S�0�1�0�9rensen is Chief Executive Officer-Nordic Region at Koninklijke Philips NV. In her past career she was Vice President-Western Europe at Sanofi SA.
Frans van Houten Frans van Houten is a Netherlands; Dutch businessperson who has been the head of 9 different companies and presently occupies the position of Chief Executive Officer for Philips Lighting Electronics (Shanghai) Co. Ltd. and Chief Executive Officer for Koninklijke Philips NV, Chief Executive Officer at Philips International BV (a subsidiary of Koninklijke Philips NV). Mr. Van Houten is also Chairman-Supervisory Board of Stichting Erasmus Trustfonds (SET) and Member of European Round Table of Industrialists and on the board of 5 other companies. He previously was President & Chief Executive Officer at Airvision LLC, Chief Executive Officer at NXP Semiconductors NV and President & Chief Executive Officer of Philips Semiconductors (a subsidiary of NXP Semiconductors NV), CEO-Consumer Electronics Businesses Group at Philips Consumer Electronics BV, VP-International Sales & Operations at PKV Verm�0�1�0�9gensverwaltung AG, Chief Executive Officer for Philips GmbH and Chief Executive Officer at Philips Lighting Holding BV. Frans van Houten received a graduate degree and an undergraduate degree from Erasmus University Rotterdam.
Marnix van Ginneken Dr. Marnix van Ginneken is a Co-Secretary, Chief Legal Officer & Executive VP at Koninklijke Philips NV and a Chairman at Stichting Beroepsopleiding Bedrijfsjuristen. He is on the Board of Directors at American Chamber of Commerce in The Netherlands, De Vereniging Effecten Uitgevende Ondernemingen, Nederlandse Juristen - Vereniging and Stichting Grotius Academie. He received his graduate degree from Wayne State University (Michigan), a graduate degree from the University of Utrecht and a doctorate degree from the University of Amsterdam.
A. Marc Harrison A. Marc Harrison is President, Chief Executive Officer & Trustee at Intermountain Health Care, Inc.
Andy Ho Andy Ho is CEO-Philips Greater China & Executive VP at Koninklijke Philips NV. He received an undergraduate degree from The Chinese University of Hong Kong.
Jan Kimpen Presently, Jan Kimpen occupies the position of Chief Medical Officer for Koninklijke Philips NV.
Sophie Bechu Ms. Sophie Bechu is a Chief Operating Officer & Executive Vice President at Koninklijke Philips NV. Ms. Bechu was previously employed as a VP-North America Delivery Strategic Outsourcing by International Business Machines Corp. She received her undergraduate degree from �0�1‰cole sup�0�1�0�8rieure d'�0�1�0�8lectricit�0�1�0�8.
John A. Frank John A. Frank is Business Leader Sleep & Respiratory Care at Koninklijke Philips NV.
Liat Ben-Zur Liat Ben-Zur founded Allseen Alliance, Inc. She is on the board of Umicore and Senior Vice President-Digital Technology at Koninklijke Philips NV. In her past career she was Chairman for Allseen Alliance, Inc. She received an undergraduate degree from the University of California, Davis and an MBA from Anderson School of Management.
Bert van Meurs Bert van Meurs is Business Leader-Image Guided Therapy at Koninklijke Philips NV. He received an undergraduate degree from Technische Universiteit Eindhoven and a graduate degree from the University of Utrecht.
Rianne Meijerman Rianne Meijerman is on the board of GrandVision NV and Head-Marketing Transformation at Koninklijke Philips NV. She received an undergraduate degree from Maastricht University.

量化对比

全部评论 32

  • 飞利浦将以37亿欧元(合43.7亿美元)的价格将其家用电器部门出售给高瓴资本。(第一财经)

  • 市场消息:飞利浦(PHG.N)预计交易总额约为44亿欧元,将于第三季度完成交易。

  • 市场消息:飞利浦(PHG.N)预计交易总额约为44亿欧元,将于第三季度完成交易。

  • 市场消息:飞利浦(PHG.N)将出售家电业务给高瓴资本。

  • 飞利浦(PHG.N)盘前涨1.3%。

  • 【昕诺飞3月5日起上调部分产品价格,上涨幅度为5%-17%】昕诺飞26日发出2021年飞利浦品牌产品价格调整通知,自3月5日起上调部分产品价格,上涨幅度为5%-17%。欧曼照明、联浩照明、旌旗照明等企业也于近日发布涨价函。

  • 【媒体:亚洲买家入围飞利浦40亿美元家电业务的第二轮竞标】据悉,飞利浦已经为可能至少卖出30亿欧元(37亿美元)的家电业务选定了几个入围的亚洲竞标者。飞利浦邀请中国私募股权公司鼎晖投资和家电制造商TCL(TCL与中信资本组队)提交第二轮竞标,高瓴资本也入围,此外至少还有一家入围竞标者。这块业务最初吸引了多家美国和欧洲大型私募股权公司的兴趣,包括PAI Partners、Apollo Global Management、Advent International和CVC Capital Partners。不过,其中几个基金近日对至少30亿欧元的要价颇有微词。

  • 【媒体:亚洲买家入围飞利浦40亿美元家电业务的第二轮竞标】据悉,飞利浦已经为可能至少卖出30亿欧元(37亿美元)的家电业务选定了几个入围的亚洲竞标者。飞利浦邀请中国私募股权公司鼎晖投资和家电制造商TCL(TCL与中信资本组队)提交第二轮竞标,高瓴资本也入围,此外至少还有一家入围竞标者。这块业务最初吸引了多家美国和欧洲大型私募股权公司的兴趣,包括PAI Partners、Apollo Global Management、Advent International和CVC Capital Partners。不过,其中几个基金近日对至少30亿欧元的要价颇有微词。

  • 【飞利浦回应e公司:中国和欧洲的战略参与者及私募对公司家电业务表现出浓厚兴趣】对于“中国部分企业拟竞标飞利浦家电资产”的最新传闻,飞利浦回应证券时报·e公司记者称,中国和欧洲的战略参与者和私募,对于飞利浦的家电业务表现出浓厚兴趣。公司已向有关方面发出资料备忘录。分拆过程正在进行中,预计在2021年第三季度完成。飞利浦同时保留所有潜在选择,包括私下出售或IPO。作为全球最大家用电器公司之一,今年一月飞利浦宣布计划出售家电业务,此前,摩根大通和高盛已经成为公司相关事宜的顾问。

  • 【外国企业对UMTS和LTE蜂窝通信模块及其产品提起337调查申请】近日,荷兰皇家飞利浦有限公司和飞利浦北美公司依据《美国1930年关税法》第337节规定,向美国际贸易委员会提出申请,指控对美出口、在美进口或在美销售的UMTS和LTE蜂窝通信模块及其产品侵犯其专利权,请求发起337调查,并发布普遍排除令、有限排除令和禁止令。中国上海移远通信技术股份有限公司为列明被申请人。

  • 【道指开盘涨0.04%,标普500涨0.1%,纳指涨0.3%】健康服务公司BioTelemetry涨17.9%,飞利浦宣布将斥资24.7亿美元收购该公司。DoorDash跌1.0%,香橼沽空Doordash,目标价40美元。理想汽车涨0.9%,理想汽车累计交付量突破30000辆,创下新造车势力首款车型最快交付纪录。

  • 【美股盘前消息速报】①美国股指期货周五盘前小幅攀升,市场聚焦英国脱欧协议,及美国财政刺激法案。今晚将迎来美股今年最后一个“四巫日”,大型衍生工具头寸的滚动通常会加大市场波动。②截至发稿,道指期货涨0.02%,标指期货涨0.1%,纳指期货涨0.1%。③英国富时100指数和德国DAX指数分别上涨了0.48%和0.19%,法国CAC指数下跌了0.07%。④黄金回落至1880美元关口下方。鉴于美国国会对于刺激法案的协议还未达成,美元因近期的超卖环境得以反弹,从而令以美元计价的黄金承压。⑤日内几乎没有重要的经济数据公布,但两大协议成为焦点——即美国刺激法案和英欧退欧贸易协议。⑥区块链板块盘前普涨,嘉楠科技涨5.8%,Bit Digital涨5.2%,Marathon Patent涨4.7%,Riot Blockchain涨2.9%。⑦Moderna盘前跌1.39%。美国食品药品监督管理局(FDA)发言人:Moderna的新冠疫苗还没有获得授权,紧急使用授权(EUA)还在审核之中。⑧健康服务公司BioTelemetry盘前涨超15%,今日飞利浦宣布将斥资24.7亿美元收购该公司。⑨ 理想汽车盘前涨2.6%,理想汽车累计交付量突破30000辆,创下新造车势力首款车型最快交付纪录。

  • 【电动车初创公司法拉第未来宣布与飞利浦签订联合开发协议】全球共享智能出行生态系统公司Faraday Future (FF)今天宣布,FF与飞利浦知识产权与标准公司达成联合开发协议,双方将合作并在FF车辆上使用基于飞利浦精选技术组合开发的汽车功能。飞利浦的健康技术和软件为FF的产品愿景及其即将推出的FF 91和FF 81豪华电动汽车增加了显著的差异化优势。

  • 【电动车初创公司法拉第未来宣布与飞利浦签订联合开发协议】全球共享智能出行生态系统公司Faraday Future (FF)今天宣布,FF与飞利浦知识产权与标准公司达成联合开发协议,双方将合作并在FF车辆上使用基于飞利浦精选技术组合开发的汽车功能。飞利浦的健康技术和软件为FF的产品愿景及其即将推出的FF 91和FF 81豪华电动汽车增加了显著的差异化优势。

  • 【2020深圳全球招商大会吸引投资总额超7800亿元】深圳市委市政府8日举行2020深圳全球招商大会,并在全球8座城市设立分会场。大会共洽谈签约项目242个,涉及投资总额超7800亿元。现场签约项目包括美国开市客华南总部项目、荷兰皇家飞利浦创新中心项目、英国阿斯利康-康泰新冠疫苗研发及生产基地项目、马来西亚IOI中国区总部项目、中国香港周大福集团商业综合体暨富通保险中国总部项目、中国台湾臻鼎科技半导体载板生产基地项目等。

  • 【商务部:美国对数字视频播放设备及其组件发起337调查】商务部消息,10月16日,美国国际贸易委员会(ITC)决定对数字视频播放设备及其组件发起337调查。该调查由荷兰皇家飞利浦公司和飞利浦北美公司于9月18日依据《美国1930年关税法》第337节规定,向ITC提出申请,指控对美出口、在美进口或在美销售上述产品侵犯其专利权,请求ITC发布有限排除令和禁止令。

  • 飞利浦:预计2021年可比销售低位数增长。

  • 飞利浦第三季度营收49.8亿欧元,预估为48.1亿欧元。

  • 【TCL科技回应飞利浦在美提起调查申请:影响有限】针对荷兰皇家飞利浦公司和飞利浦北美公司向美国国际贸易委员会(ITC)提出337调查申请事宜,TCL科技相关负责人表示,“影响有限”。此前,飞利浦向ITC提出337调查申请事宜,指控对美出口、在美进口和在美销售的数字视频播放设备及其组件(Certain Digital Video-Capable Devices and Components Thereof)侵犯其专利权,请求ITC发起337调查,并发布有限排除令和禁止令,涉及TCL科技、海信集团等。

  • 【TCL科技回应飞利浦在美提起调查申请:影响有限】针对荷兰皇家飞利浦公司和飞利浦北美公司向美国国际贸易委员会(ITC)提出337调查申请事宜,TCL科技相关负责人表示,“影响有限”。此前,飞利浦向ITC提出337调查申请事宜,指控对美出口、在美进口和在美销售的数字视频播放设备及其组件(Certain Digital Video-Capable Devices and Components Thereof)侵犯其专利权,请求ITC发起337调查,并发布有限排除令和禁止令,涉及TCL科技、海信集团等。

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐